Joseph Zackular, PhD highlights targeting high-risk groups for vaccination and shares insights into the future of mRNA vaccine development for C diff.
Joseph Zackular, PhD
Advertisement
Assistant Professor at the Children's Hospital of Philadelphia and the University of Pennsylvania.
Articles by Joseph Zackular, PhD
Joseph Zackular, PhD suggests that mRNA vaccines and monoclonal antibodies could offer more effective treatments for recurrent C difficile infections
Joseph Zackular, PhD, shares insights on his team’s mRNA vaccine research for C difficile, highlighting progress in animal models and future plans for human trials.
Advertisement
Latest Updated Articles
mRNA Vaccine Shows Potential for C difficile InfectionsPublished: December 16th 2024 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Phase 3 Trial Confirms Superior Efficacy of Oral Pritelivir for Refractory HSV in Immunocompromised Patients
2
Invivyd Announces FDA Clearance of IND Application for VYD2311 and Advancement of REVOLUTION Clinical Program
3
UCF Team Advances Low-Cost Multiplex RNA Test for HIV, HBV, and HCV
4
